Lung Cancer -

icnet.uk - by Moose and Doc

lung cancer icnet.uk Moose and Doc Lung Cancer

April 26, 2015 By Steven Halls

This page is the continuation of references in support of Section 6D

REFERENCES

American Cancer Society: Cancer Facts and Figures 2014. Atlanta: American Cancer Society. (Retrieved 19th Feb 2015): http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf

Ellis PM, Blais N, Soulieres D et al. (2011). A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer. J Thorac Oncol. 6(8):1379-91. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed?term=21709590

Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5)(suppl):e93S-e120S. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749714/

Grossi F. Management of non-small cell lung in cancer patients with stable disease. Drugs. 2012; 72 Suppl 1:20-27. (Retrieved 19th Feb 2015): http://link.springer.com/article/10.2165%2F1163013-S0-000000000-00000

Kerr KM, Bubendorf L, Edelman MJ, et al. Panel Members. (2014). Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Ann Oncol 25(9), 1681-90. (Retrieved 20th Feb 2015): http://annonc.oxfordjournals.org/content/25/9/1681.full.pdf+html

Rami-Porta R, Crowley JJ, Goldstraw P. (2009). The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 15(1), 4–9. (Retrieved 10th Feb 2015): http://www.atcs.jp/pdf/2009_15_1/4.pdf

Rusch VW, Asamura H, Watanabe H, et al. (2009). The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4:568. (Retrieved 19th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/19357537

Sica G, Yoshizawa A, Sima CS, et al. (2010). A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 34(8), 1155–1162. (Retrieved 10th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/20551825

Schreiber G, McCrory DC. (2003). Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 123(1 Suppl), 115S. (Retrieved 19th Feb 2015): (Retrieved 19th Feb 2015): http://journal.publications.chestnet.org/article.aspx?articleid=1081260

Travis WD, Colby TV, Corrin B, et al, eds. Histological typing of lung and pleural tumours. WHO international histological classification of tumours, 3rd ed. Berlin: Springer, 1999.

Travis WD, Brambilla E, Noguchi M, et al. (2011). International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6(2), 244–285. (Retrieved 10th Feb 2015): http://www.ncbi.nlm.nih.gov/pubmed/21252716

Wang GF, Lai MD, Yang RR et-al. (2006). Histological types and significance of bronchial epithelial dysplasia. Mod. Pathol 19 (3), 429-37. (Retrieved 10th Feb 2015): http://www.nature.com/modpathol/journal/v19/n3/full/3800553a.html

WHO Classification of Tumors of the Lung. 3rd Edition. (Retrieved 10th Feb 2015): http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf

Yi ES, Boland JM, Maleszewski JJ et al. (2011). Correlation of immunohistochemistry (IHC) and fluorescent in-situ hybridization (FISH) for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH. J. Thorac. Oncol 6,459–465. (Retrieved 19th Feb 2015): http://journals.lww.com/jto/Fulltext/2011/04000/Correlation_of_IHC_and_FISH_for_ALK_Gene.30.aspx

 

Did you click on any pictures to hear music, or find other surprises?.

 

Copyright © 2014–2023 · by Steven Halls, MD · steve@halls.md ·1-780-608-9141 · Log in